RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents

Grant

Date/time Interval

  • September 1, 2017 - August 31, 2022
  • Total Award Amount

  • 711970.00
  • Direct Costs

  • 479441.00
  • Sponsor Award Id

  • P01CA210946
  • Contributor

  • Donald Muccio PhD   Investigator  
  • Matthew Renfrow Ph.D.   Principal Investigator